Heavy and light chains from immunoglobulins, that are contaminants from your immunoprecipitation process, were detected in samples loaded under non-reducing buffer conditions (indicated by “*” in Physique ?Figure2B2B). From these results it is concluded that monoclonal F-E2G5 antibody has the propensity to immunoprecipitate YB-1-GFP as well as endogenous YB-1 protein, however, detection by means of immunoblotting BACE1-IN-1 with the utilized polyclonal anti-YB-1 antibody is susceptible to the chosen buffer conditions. Mab F-E2G5 is suitable for YB-1 immunodetection in formalin-fixed paraffin-embedded breast cancer tissue From our previous studies it was clear that this fixation process markedly affects detection of YB-1 in rat tissue [43]. evaluation of Mab F-E2G5 was performed by immunohistochemistry of a human breast malignancy tissue microarray comprising 179 invasive breast cancers, 8 ductal BACE1-IN-1 carcinoma from their corresponding columns, and scaling is done by dividing the (centered) columns of by their root-mean-square. Explanatory variables were considered statistically significant when P < 0.05. Results Characterization of monoclonal YB-1-specific antibody F-E2G5 In a first approach the F-E2G5 antibody was examined for its substrate specificity by western blot analysis using cell extracts from HEK293 cells expressing GFP, YB-1-GFP or YB-1(21-147)-GFP proteins. GFP and YB-1-GFP fusion protein expression was ascertained by detection with monoclonal GFP antibody (Physique ?(Physique1A,1A, lanes 1-3). Immunoblotting with biotinylated F-E2G5 Mab was performed following addition of non-reducing (lanes 4-6) or reducing buffer (lanes 7-8) to protein samples. Mab F-E2G5 detects full-length YB-1-GFP fusion protein and also the truncated protein encompassing amino acids 21-147. However, detection succeeds only with non-reducing buffer and not under reducing buffer conditions with inclusion of mercaptoethanol (Physique ?(Physique1A,1A, compare lanes 5 and 7). Endogenous YB-1 protein with a relative molecular excess weight of 50 kDa was not detected by immunoblotting using F-E2G5 antibody, neither in denaturing nor in non-denaturing gels (data not shown). These results indicate that (i) the epitope(s) recognized by F-E2G5 resides within the YB-1 protein domains aa21-147 and (ii) detection is highly susceptible to the chosen conditions of western blotting. Open in a separate window Physique 1 Detection of YB-1-GFP LRP1 and YB-1(21-147)-GFP by immunoblot and recombinant YB-1 by ELISA. (A) HEK293T cell extracts made up of GFP (lanes 1 and 4), YB-1-GFP (lane 2, 5 and 7) or YB-1(21-147)-GFP proteins BACE1-IN-1 (lanes 3, 6 and 8) were separated in denaturing gels and following transfer to nitrocellulose probed with GFP antibody (lanes 1 to 3) or Mab F-E2G5 (lanes 4 to 8). Relative mobilities of expressed proteins are indicated by arrowheads. Notably, reducing sample buffer prevents detection of tagged YB-1 proteins by immunoblot (lanes 7 and 8). (B) ELISA was performed by covering with recombinant affinity purified hexahistidin-tagged YB-1 protein. Biotin-labeled Mab F-E2G5 yields an even stronger transmission than non-biotinylated Mab. Controls included omission of antibody (Con1) or antigen (Con2). One may conclude that this GFP-tag stabilizes the YB-1 protein conformation and permits successful detection by means of Mab F-E2G5, as the endogenous YB-1 protein from cell lysates (~50 kDa) was not detected by western blotting (only minute amounts were immunopositive following prolonged exposure). To ensure that Mab F-E2G5 successfully binds YB-1 protein under non-reducing and non-denaturing conditions, we thereafter established a direct ELISA with recombinant, affinity-purified YB-1 protein expressed in E. coli. Biotinylated as well as non-biotinylated Mabs F-E2G5 were tested. Under both conditions recombinant YB-1 protein was detected (Physique ?(Physique1B),1B), even better with biotinylated Mab F-E2G5. Controls included omission of antibody (Con1) or antigen (Con2) and addition of irrelevant IgG2/irrelevant biotinylated IgG2 antibody (not shown), all BACE1-IN-1 yielding unfavorable results. Thus, Mab F-E2G5 binds epitope(s) that reside BACE1-IN-1 within YB-1 protein domains aa21 to 147. In addition, a sandwich ELISA was established with a series of GFP-tagged fusion proteins that include the following domains of YB-1 protein: aa21-147, aa146-317, aa146-225, aa146-172, aa260-317, aa146-262, aa21-262. Biotinylated Mab.